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Abstract
Poor iron status is a global health issue, affecting two thirds of the world population to some degree. It is a particular
problem among pregnant women, in both developed and developing countries. Feeding pregnant rats a diet deficient in
iron is associated with both hypertension and reduced nephron endowment in adult male offspring. However, the
mechanistic pathway leading from iron deficiency to fetal kidney development remains elusive. This study aimed to
establish the underlying processes associated with iron deficiency by assessing gene and protein expression changes in the
rat embryo, focussing on the responses occurring at the time of the nutritional insult. Analysis of microarray data showed
that iron deficiency in utero resulted in the significant up-regulation of 979 genes and down-regulation of 1545 genes in
male rat embryos (d13). Affected processes associated with these genes included the initiation of mitosis, BAD-mediated
apoptosis, the assembly of RNA polymerase II preinitiation complexes and WNT signalling. Proteomic analyses highlighted 7
proteins demonstrating significant up-regulation with iron deficiency and the down-regulation of 11 proteins. The main
functions of these key proteins included cell proliferation, protein transport and folding, cytoskeletal remodelling and the
proteasome complex. In line with our recent work, which identified the perturbation of the proteasome complex as
a generalised response to in utero malnutrition, we propose that iron deficiency alone leads to a more specific failure in
correct protein folding and transport. Such an imbalance in this delicate quality-control system can lead to cellular
dysfunction and apoptosis. Therefore these findings offer an insight into the underlying mechanisms associated with the
development of the embryo during conditions of poor iron status, and its health in adult life.
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Introduction
It is now well-established that early life exposure to an adverse
nutritional environment can programme aspects of adult anatomy,
physiology and metabolism and thereby determine risk of
cardiovascular and metabolic disorders [1–3]. Evidence from
retrospective cohort studies shows that anthropometric markers of
sub-optimal maternal nutritional status during fetal development
are predictive of cardiovascular disease, type-2 diabetes and
chronic kidney disease [4,5]. Experiments in animals that have
manipulated either overall food supply or dietary composition
such that one or more nutrients is limiting, strongly support the
hypothesis that during nutritional stress, the fetus mounts adaptive
responses in order to preserve growth or survival [6–11]. In the
long-term the modifications to organ structure, hormone re-
sponsiveness or gene expression, which characterise the adaptation
to stress, predispose to disease in later life.
On a global scale, iron deficiency is the most prevalent
manifestation of malnutrition. Poor maternal iron status is
a recognised risk factor for preterm delivery, low birthweight
and neonatal death, particularly in developing countries [12,13].
Iron deficiency anaemia is highly prevalent in many populations
and in some parts of the world more than half of pregnant women
will be affected. A number of rodent studies indicate that the
imposition of iron deficiency prior to and during pregnancy has
long-term effects upon the resulting offspring, with reports of high
blood pressure [11,14–16], impaired nephrogenesis [17] and
altered glucose handling [16].
The mechanistic basis of this nutritional programming of
disease has not been fully explored. Much of the research focus has
been upon postnatal events and the progression from what is
usually a low birthweight phenotype, to adult pathology. One of
the outcomes of such work has been the observation that
undernutrition frequently results in a remodelling of tissue
structure [18–21]. For example, in the kidney, diverse nutritional
insults including maternal protein restriction, food restriction and
iron deficiency, lead to a lower nephron number in the offspring
[22–24]. This, arguably, may be a driver of the renal and
cardiovascular outcomes which are also associated with nutritional
insult. Such studies do not, however, capture the primary response
to undernutrition or explain how tissue morphology is pro-
grammed by the maternal diet. Studies of specific candidate genes
suggest that there may be modifications to the epigenome which
establish altered patterns of gene expression [25–27]. However, to
date, there is no convincing evidence that these epigenetic
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modifications are widespread, or that they modulate expression of
genes of relevance to renal or cardiovascular disease.
We have previously hypothesised that nutritional programming
of physiological function occurs through changes in a limited
number of ‘‘gatekeeper’’ processes [24]. These are genes or gene
pathways for which the adaptive response during development is
common to all of nutritional insults. Earlier work in our
laboratories considered the mechanistic basis of programming in
two separate nutritional programming models (iron deficiency and
protein restriction), across two rat strains. By comparing whole
genome array and proteomics data across both models and strains,
this work identified a number of putative gatekeeper genes,
proteins and processes which may offer a generalised mechanism
to explain the common phenotypes exhibited by offspring of
pregnant rats exposed to diverse nutritional insults [24]. The
experimental approach used in this previous study discarded gene
or protein expression changes which only occurred in response to
one of the dietary treatments or in one of the strains of rat, as the
lack of replication across models suggested that these were not
central mechanisms to the programming of a common phenotype.
However, the existence of a common phenotype in response to
different dietary insults is not universally accepted and it may be
the case that the common endpoints observed are actually a non-
specific consequence of different programming pathways. The
wealth of data produced from each model within the original
gatekeeper study is worthy of more in depth analysis for
identification of diet specific mechanisms. The previously reported
analysis was constrained by the low numbers of gene targets which
were differentially expressed across two rat strains and two
nutritional interventions. The data analysis reported in this further
paper focuses on the response of the embryonic genome and
proteome to maternal iron deficiency in the Rowett Hooded Lister
rat and exploits a larger pool of differentially expressed genes for
pathway analysis and increases confidence in the demonstrated
role of maternal nutritional status as a regulator of cell cycle in the
developing embryo. As before, any significant changes in gene and
protein expression will not automatically suggest a causal relation-
ship with the observed phenotypic changes such as increased blood
pressure, but pathway analysis may shed light on the potential
mechanisms at play early in the programming process.
Materials and Methods
Ethical Approval
All animal experiments were performed in the BioResources
Unit of the University of Nottingham, under license from the
United Kingdom Home Office in accordance with the 1986
Animals (Scientific Procedures) Act. The study was approved by
the UK Home Office (Project Licence PPL40/2990) and
University of Nottingham Ethics Committee (approval ID SLE/
005/07).
Animals
As previously reported [24], 16 female Rowett Hooded Lister
(RHL) rats (Rowett Institute of Nutrition and Health, University of
Aberdeen, UK) were subjected to a 12h light (08:00–20:00)-dark
(20:00–08:00) cycle at a temperature of 20–22uC with ad libitum
access to food and water. For 4 weeks prior to mating, half of the
rats were fed a control iron (50 mg Fe/kg; FeC) diet and the other
half an iron deficient diet (7.5 mg Fe/kg; FeD; [11]) to ensure
depletion of iron stores during pregnancy. Iron-deficient diets were
isocaloric relative to the control diet. Previous studies in our
laboratories have shown that this protocol reproducibly reduces
both maternal and fetal liver iron content by approximately 70%
and 50% respectively [11,28,29] Cornock et al., unpublished
observation). At a weight of approximately 180–200g, females
were mated with stud males. After conception, determined by the
presence of a semen plug on the cage floor, females were single-
housed and remained on their pre-pregnancy diet. During
pregnancy the animals were weighed and food intake was
recorded daily. This protocol has been previously demonstrated
to result in elevated systolic blood pressure and lower nephron
number in the adult offspring [11,24].On day 13 of gestation,
pregnant females were culled by CO2 asphyxia and cervical
dislocation. Individual embryos and placentas were harvested and
RNA and protein prepared from a pool of all male embryos within
a litter as described previously [24].
Microarray
An Affymetrix Genetitan Rat 230 microarray was performed by
Service XS. This array comprises over 31,000 probe sets,
analysing over 30,000 transcripts and variants from over 28,000
well-substantiated rat genes, as well as positive and negative
controls. Before the labelling process, the integrity of all RNA
samples was further checked using the Agilent 2100 Bioanalyser.
Output data were supplied as Affymetrix CEL files and loaded
into Genespring (Agilent). Data were normalised to QC controls
and samples assigned to the appropriate diet group. Data were
loaded into MetaCore (GeneGo) to identify pathways affected by
iron deficiency. All microarray data is MIAME compliant and the
raw data has been deposited in ArrayExpress (accession number
E-MTAB-664).
Real-time PCR
Real-time PCR was performed on the same embryonic RNA
sample that was prepared for microarray, to further explore some
of the gene expression changes observed in the microarray
analysis. RNA was reverse transcribed using Moloney murine
leukemia virus (MMLV) reverse transcriptase (Promega) and real
time PCR was performed using Probe Master Mix (Roche) and
Taqman Rat Custom Expression Assays (ABI) on a Lightcycler
480 (Roche) in 384-well optical reaction plates. Expression values
and linearity were determined using a cDNA standard curve. Data
were normalised to total cDNA levels measured by Oligreen
reagent (Invitrogen) at 80uC [30].
Proteomics
Proteomic analysis was carried out by the Proteomics Section at
the Rowett Institute of Nutrition and Health (University of
Aberdeen). Protein samples were loaded onto sixteen 8–16%
acrylamide gels to separate proteins in each embryo sample by
isoelectric focussing in the first dimension (pI range 3–10) and
SDS-PAGE in the second dimension. Gels were stained using the
Colloidal Coommasie stain method, and imaged on a Bio-Rad
GS800 scanning densitometer, followed by analysis using Progen-
esis SameSpots software. Each image was quality assessed before
selection of a ‘master gel’, to which the other 15 gels were aligned.
Gels were assigned to either the FeC or FeD group and any spots
with differences in area and density between groups were
identified by ANOVA. Spots of interest were hand-cut from the
SDS-PAGE gels. In-gel digestion and trypsinisation of the cut
spots was performed on a Proteome Works System, Mass PREP
Station Robotic Handling System and extracted peptides were
analysed on a nano LC-MS/MS system using Q-Trap. The total
ion current data was searched against the MSDB database using
the MASCOT search engine (Matrix Science) with the following
search criteria: allowance of 0 or 1 missed cleavages; peptide mass
tolerance of 61.5 Da; fragment mass tolerance of 61.5 Da,
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trypsin as digestion enzyme; carbamidomethyl fixed modification
of cysteine; methionine oxidation as a variable modification; and
charged state as 2+ and 3+. The highest MASCOT results were
further selected for best matches with criteria of protein
identifications having a Mascot score higher than 40 (threshold)
and more than one peptide match. The identification was
considered only with a combination of the highest Mascot score
and maximum peptide coverage.
Statistical Analysis
All data was analysed using the Statistical Package for Social
Sciences (SPSS, Inc, Chicago, IL, Version 18.0). Differences
between groups were assessed using an independent t-test, unless
indicated otherwise in the text. Values are expressed as mean 6
SEM. P,0.05 was considered as significant.
Results
Maternal Weight Gain and Reproductive Performance
There was no difference in the body weights of dams in the iron
deficient and control iron groups either at the commencement of
pregnancy or at the time of embryo collection (day 13 of
pregnancy; Table 1). Weight gain and average daily food intake
(calculated from food remaining in hopper) was similar between
the two groups and iron intake was, as expected, 6-fold higher in
the control group (P,0.001). While the number of male embryos
collected did not differ with maternal diet, those fed an iron
deficient diet produced significantly fewer embryos in total
(P,0.03).
Microarray
2524 genes were differentially regulated between control and
iron deficient embryos (P,0.05). Of these, 979 genes were up-
regulated with iron deficiency and 1545 genes were down-
regulated. Despite the severity of the maternal insult, the
magnitude of the expression changes was generally modest and
the greatest expression changes were for sex-determining region Y-
box 4 (SOX4; 2.34-fold up-regulation with iron deficiency;
P,0.04) and microtubule-associated protein 1B (Map1b; 2.21-fold
up-regulation with iron deficiency; P,0.02). The greatest down-
regulations in gene expression occurred with myosin VC (Myo5c;
0.63-fold change; P,0.01) and S100 calcium-binding protein A6
(S100a6; 0.69-fold change; P,0.01). The 20 genes exhibiting the
greatest fold-changes up or down in relation to control are listed in
Table 2. A full list of differentially regulated genes is provided in
Table S1.
Pathway Analysis
Pathway analysis was performed using the MetaCore platform
to identify the functional processes associated with the significant
gene expression changes following exposure of the embryo to
maternal iron deficiency. The pathways which were most
significantly affected (Figure 1; P,0.0003) were mostly due to
down-regulation of associated genes. 19–42% of pathway genes
were differentially regulated. These pathways were concerned with
initiation of mitosis (associated genes: cdk1, cdk7, ccnb1, ccnb2, ccnh,
AP-2A, Mnat1, Akt, APC; 36% of total pathway genes significantly
regulated), BAD phosphorylation (G-protein B, PDK, Akt, PKA,
cDK1, JNK1, IRS-1, cytochrome c; 26% of genes), assembly of RNA
polymerase II preinitiation complex (TFII-I, APP, PCNA, Mxi1,
DHFR; 38% of genes), nucleocytoplasmic transport of CDK/
cyclins (42% of genes), WNT signalling (21% of genes), PGE2 in
cancer (20% of genes), PIP3 signalling in cardiomyocytes (21% of
genes), regulation of CFTR activity (19% of genes), prolactin
receptor signalling (19% of genes) and NF-AT signalling in cardiac
hypertrophy (25% of genes) (Figure 1). The pathway analyses
identified a number of transcription factors which appeared to act
as central ‘‘hubs’’, or linkers, of other pathways and processes
including organ development and cellular metabolic processes.
SP1 interacted with 303 network objects or genes which were
differentially expressed in iron deficient embryos (Table S1) (e.g.
Pole-3, NCOA3), p53 with 102 (e.g. cyclin H, Sumo-1) and c-myc with
203 (e.g. STAT3, Txn1). The expression of these transcription
factors was determined by real-time PCR (see below).
Real-time PCR
The expression of ten genes and the three transcription factors,
identified by microarray analysis to be differentially expressed in
the iron deficient embryo, was also confirmed using real-time
PCR. In line with the key processes identified by the pathway
analysis, these genes had a range of functions including regulation
of cell growth and proliferation and cancer development (PSAT1,
Hint, SDCCAG10, p53 and C-myc), cell cycle (Ube2c, Hint, GMPS and
p53), apoptosis (Hint), protein synthesis and folding (SDCCAG10,
TOMM34, eEF1G), cardiac muscle growth (USMG5) and de-
velopmental processes (TBX3, FGFR1). SP1 and c-myc were down-
regulated in embryonic tissue in response to maternal iron
deficiency (Figure 2). The expression of p53 was increased by
more than 5-fold in the iron deficient embryos. These results are
supported by findings that iron induces the expression of c-myc [31]
and SP1 [32], while inhibiting p53 expression via the induction of
mdm2 [33]. The change in expression of these transcription factors
would therefore have implications for the many downstream target
genes identified by the pathway analysis (e.g. see above; Pole-3: FC
0.81, P,0.01; NCOA3: FC 1.19, P,0.01; Cyclin H: FC 0.93,
P,0.03; Sumo-1: FC 0.89, P,0.001; STAT3: FC 1.25, P,0.007;
Txn1: FC 0.94, P,0.03). The real-time PCR analysis of the gene
targets identified in the microarray and pathway analysis generally
supported the outcome of the microarray results (Table 3).
Although the fold-changes identified by microarray were generally
small (though highly significant), for seven out of the ten genes we
showed good agreement between array and real-time PCR in
terms of statistical significance and the direction of change in
expression. Only Hint, eEF1G and FGFR1 failed to show
consistency between the two methods, as although significant
differences in expression were noted between controls and iron
deficient embryos, these genes were up-regulated by rtPCR
compared to down-regulated in the arrays.
Table 1. Maternal weight gain, food intake and reproductive
performance (FeC = control iron; FeD= iron deficient;
BW=body weight; D13 =day 13 of pregnancy; NS = not
significant).
FeC FeD P
n 8 8
BW at conception (g) 223.967.7 231.369.2 NS
BW at D13 (g) 285.565.7 295.268.9 NS
BW gain (g) 61.664.7 63.963.0 NS
Average food intake (g/day) 26.762.5 29.662.4 NS
Maternal iron intake (mg/day) 1.360.1 0.260.02 0.001
No. of embryos 14.460.8 11.360.6 0.03
No. of male embryos 6.460.9 5.160.2 NS
doi:10.1371/journal.pone.0048133.t001
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Proteomics
Proteomics analysis identified 7 proteins which were signifi-
cantly up-regulated in FeD embryos compared to FeC, and 11
proteins which were down-regulated with iron deficiency
(Table 4). Many of the identified proteins play important roles
in cell proliferation (alpha-enolase, ADP-ribosylation factor-like 3,
nucleophosmin, prohibitin, dihydrofolate reductase), protein
transport and folding (ADP-ribosylation factor-like 3, nucleophos-
min, vasolin-containing protein, Chaperonin containing TCP1,
subunit 5), cytoskeletal remodelling (ADP-ribosylation factor-like
3, Chaperonin containing TCP1, subunit 5) and the proteasome
complex (SUG1, Proteasome subunit alpha type 3-like).
Dihydrofolate reductase (microarray: 0.88-fold change,
P,0.001; proteomics: 0.8-fold change, P,0.04) and proteasome
alpha-3 (microarray: 0.92-fold change, P,0.02; proteomics: 0.8-
fold change, P,0.01) also showed significant changes in gene
Table 2. Genes showing the greatest increase or decrease in expression in FeD embryos (n = 8) relative to controls. FC = fold-
change.
Accession Number p-value FC Gene Symbol Gene Title
BE115519 0.04 2.35 Sox4 SRY (sex determining region Y)-box 4
BG378086 0.02 2.21 Map1b Microtubule-associated protein 1B
BE110516 0.02 1.97 RGD1563798 Similar to BC040823 protein
BE116127 0.00 1.92 RGD1564560 Similar to RCK
BF522283 0.04 1.91 Ppp2r4 Protein phosphatase 2A activator, regulatory subunit 4
BF562309 0.03 1.85 Ng35 Ng35 pseudogene
BI290608 0.02 1.77 Adipor2 Adiponectin receptor 2
BF562800 0.05 1.75 LOC683788 Similar to Fascin (Singed-like protein)
AF389425 0.02 1.73 Dpysl3 Dihydropyrimidinase-like 3
AI073272 0.05 1.69 Tor1b Torsin family 1, member B
BF407469 0.02 1.67 Mbrl Membralin
AI236185 0.03 1.63 Rcc2 Regulator of chromosome condensation 2
X74211 0.01 1.60 Map2 Microtubule-associated protein 2
BF389675 0.03 1.57 Cbx1 Chromobox homolog 1 (HP1 beta homolog Drosophila )
AI228656 0.03 1.56 Znf618 Zinc finger protein 618
BE111692 0.01 1.55 Myst3 MYST histone acetyltransferase (monocytic leukemia) 3
BF398680 0.02 1.52 Map4k4 Mitogen-activated protein 4 kinase 4
NM_021597 0.03 1.51 Eif2c2 Eukaryotic translation initiation factor 2C, 2
AW525560 0.02 1.50 LOC683788 Similar to Fascin (Singed-like protein)
L38247 0.05 1.48 Syt4 Synaptotagmin IV
BF420807 0.01 0.63 Myo5c Myosin VC
AF140232 0.01 0.69 S100a6 S100 calcium binding protein A6
AA817746 0.03 0.70 LOC365985 Similar to adenylate kinase 5 isoform 1
NM_033234 0.03 0.72 Hbb Hemoglobin, beta
AI179412 0.00 0.72 Frrs1 Ferric-chelate reductase 1
AW535082 0.00 0.73 Mthfs 5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)
BM390697 0.01 0.73 Gca Grancalcin
AB001382 0.02 0.74 Spp1 Secreted phosphoprotein 1
AA819034 0.01 0.75 isg12(b) Putative ISG12(b) protein
AI105366 0.00 0.75 Pyroxd2 Pyridine nucleotide-disulphide oxidoreductase domain 2
NM_020082 0.01 0.75 Rnase4 Ribonuclease, rnase A family 4
BI282268 0.04 0.75 Hdhd2 Haloacid dehalogenase-like hydrolase domain 2
NM_017134 0.01 0.75 Arg1 Arginase, liver
AI176041 0.01 0.76 Pir Pirin (iron-binding nuclear protein)
AI029991 0.00 0.76 Clec1b C-type lectin domain family 1, member b
AI548039 0.00 0.76 Nepn Nephrocan
NM_080890 0.00 0.76 As3mt Arsenic (+3 oxidation state) methyltransferase
BF284695 0.03 0.77 Wdr43 WD repeat domain 43
BF418169 0.00 0.77 Trex2 Three prime repair exonuclease 2
NM_020308 0.05 0.77 Adam15 A disintegrin and metallopeptidase domain 15 (metargidin)
doi:10.1371/journal.pone.0048133.t002
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expression with the microarray, in the same direction as the
proteomics analysis. In addition, Chaperonin containing TCP1,
subunit 8, was also significantly down regulated in the microarray
(0.9-fold change, P,0.004; subunit 5 protein: 0.8-fold change,
P,0.004).
Alpha enolase was identified as both an up-regulated and down-
regulated protein. This is probably due to the membrane
translocation of the enzyme which is allowed through post-
translational modifications such as acylation or phosphorylation
[34].
Discussion
The aim of this study was to explore the underlying mechanistic
pathways which may explain the development of metabolic disease
following in utero exposure to iron deficiency in a well-established
rat model. We have previously suggested that a limited number of
gatekeeper processes could explain the common phenotype which
manifests in offspring of both prenatal iron and protein restriction
in two different strains of rat [24]. However, the current study is
Figure 1. Significant GeneGo pathways affected by prenatal iron restriction in RHL rats. Processes are ranked based upon p-value
(P,0.0003), bars represent inverse log of the p-value.
doi:10.1371/journal.pone.0048133.g001
Figure 2. Transcription factor expression in embryos exposed
to control (FeC) and iron deficient (FeD) diets, measured by RT-
PCR and normalised with Oligreen; data shown as mean 6 SE;
n=8; *P,0.05.
doi:10.1371/journal.pone.0048133.g002
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much more specific and aimed to establish if additional, or
alternative, diet-specific pathway responses occur with iron
deficiency alone in RHL rats. Such responses may be associated
with the reduced nephron endowment and increase in blood
pressure previously found in this cohort [24] compared to the
offspring of iron-replete controls, although this study did not set
out to establish definitive causality.
This study was well powered to confidently identify differences
in gene and protein expression between groups, and in excess of
2500 embryonic genes were found to be differentially expressed
with maternal iron deficiency compared to exposure to a control
diet. This offered a much greater and varied pool of genes to work
with than the original gatekeeper study, which only considered the
153 gene changes reflected by both diets, or both strains. Pathway
analysis of microarray data allows this mass of data to be refined so
that the specific processes affected by maternal iron deficiency can
be identified. In the previous gatekeeper study [24], aspects of cell
cycle regulation represented four of the seven most significant
pathways. It is noteworthy that the pathway most significantly
impacted by iron deficiency in RHL embryos was the initiation of
mitosis. This to some extent confirms the findings of our earlier
study [24]. Specific genes affected in this pathway included cdk1,
cdk7, Cyclin B1, Cyclin B2 and Cyclin H.
Cdk1 and cyclin B form a complex initiating the onset of mitosis,
shuttling back and forth between the nucleus and cytoplasm. Their
gene expression, the initiation of mitosis and nucleocytoplasmic
transport of cdk and cyclins were significantly affected by iron
deficiency. Phosphorylation of the BH3-only protein BAD was the
second most impacted process with iron deficiency. This is
important during development when neuron numbers are
controlled to ensure the correct architecture of the nervous system
(Konishi et al, 2002). Iron deficiency specifically affected the WNT
signalling pathway’s role in development. During embryogenesis,
WNT proteins are involved in regulation of cell fate and
patterning.
The two genes demonstrating the greatest up-regulation with
iron deficiency were SOX4 and Map1b. SOX4 is a transcription
factor involved in the regulation of embryonic development and
determination of cell fate. The protein may function in the
apoptosis pathway leading to cell death and tumorigenesis. Map1b
is involved in microtubule assembly, and plays an important role
in development and function of the nervous system [35]. The two
most down-regulated genes with iron deficiency were Myo5c and
S100a6. Myo5c is involved in transferrin trafficking, and therefore
plays an essential role in iron uptake and the regulation of cell
proliferation. It is also likely to power actin-based membrane
trafficking in a number of tissues. S100 proteins are involved in the
Table 3. Microarray and Real-time PCR determination of gene
targets in whole embryonic tissue exposed to a maternal iron
deficient diet, relative to a control iron diet (FC = Fold change);
n = 8.
Gene Accession No. Microarray PCR
P value FC P value FC
TBX3 BE113656 0.009 0.76 0.03 0.75
SDCCAG10 BF416387 0.018 0.85 0.03 0.66
TOMM34 AI412736 0.015 0.87 0.03 0.69
PSAT1 AI230228 0.021 0.93 0.01 0.6
USMG5 AA891707 0.017 0.90 0.01 0.61
GMPS BI283031 0.011 0.92 0.01 0.59
UBE2C BI296084 0.039 0.94 0.001 0.45
HINT AI227884 0.006 0.96 0.009 4.0
eEF1G BM391203 0.014 0.95 0.08 2.50
FGFR1 BI275155 0.047 0.88 0.03 1.93
doi:10.1371/journal.pone.0048133.t003
Table 4. Proteins identified to be significantly differentially regulated by mass spectrometry following 2D gel electrophoresis.
Direction FeD to control Protein Function
Up Alpha-enolase Glycolysis; Cell proliferation
Trypsin I precursor Digestion
Carbonyl reductase Reduction catalyst
ADP-ribosylation factor-like 3 Cell proliferation; Cytoskeletal remodelling; Protein trafficking
Fructose-biphosphate aldolase A Glycolysis, gluconeogenesis
Farnesyl-pyrophosphate synthetase Steroid/lipid synthesis
SUG1 26S Proteasome subunit
Down ?ihydropyrimidinase-related protein 2 Cytoskeletal remodelling
Chaperonin containing TCP1, subunit 5 (Epsilon) Protein folding; Cytoskeletal remodelling
Valosin-containing protein Export of misfolded proteins
Alpha-enolase Glycolysis; Cell proliferation
Phosphopyruvate hydratase Glycolysis, gluconeogenesis
Nucleophosmin Protein chaperone; Cell proliferation
Proteasome subunit alpha type 3-like Proteasome complex
Prohibitin Protein chaperone; Cell proliferation
Dihydrofolate reductase Folate metabolism; Cell proliferation
Transthyretin precursor Thyroxine and retinol transport
Dihydrolipoamide S-acetyltransferase Pyruvate dehydrogenase complex
doi:10.1371/journal.pone.0048133.t004
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regulation of cellular processes such as cell cycle progression and
differentiation. S100a6 may indirectly play a role in the re-
organization of the actin cytoskeleton and in cell motility [36]. It
was not surprising that a number of other iron metabolism genes
were also down-regulated, to a lesser extent (Table S1; e.g. pirin,
calreticulin, ferric-chelate reductase). Maternal iron deficiency
may be expected to have a major impact upon all iron-regulated
pathways in the embryo. However, we observed no change in
expression of the main iron storage and transport proteins
(transferrin, ferritin, transferrin receptor, hepcidin). This may
indicate that the programming effects of maternal iron deficiency
may not be solely or simply mediated by a gross reduction in iron
supply to the developing embryo or fetus. Other mechanisms such
as endocrine imbalance across the placenta and resetting of
epigenetic marks are known to be involved in programming
responses to undernutrition [37,38].
The iron requirements of the day 13 embryo are likely to be
small in comparison to that of the mother and may be largely met,
even in the face of maternal deficiency, which may explain why no
change in expression of the transport proteins was observed.
Previous work by the authors determined that during pregnancy
the maintenance of iron stores are prioritised towards fetal needs
at the expense of the mother. It was demonstrated that despite
a significant decrease in maternal liver iron content from day 0 of
pregnancy in iron-deficient dams, hematocrit (Hct) levels were
maintained throughout the first half of pregnancy, falling by day
21 [39]. Fetal liver iron and Hct levels measured at day 21.5
mirrored maternal concentration at the same point of gestation,
i.e. they were decreased with iron-deficiency. At day 21.5 of
gestation, placental and maternal liver transferrin receptor (TfR)
expression was increased with iron-deficiency. An elevation in
placental TfR was also found in iron-deficient day 20 placenta
(FC: 3.21, P,0.03; unpublished data). Fetal liver TfR expression
was unchanged by maternal iron deficiency throughout pregnancy
[39], while TfR2 expression was decreased. In this study, day 13
embryos were too early in development to measure equivalent
changes. Fetal transferrin expression is low in early-mid gestation
and does not begin to increase until around day 18 [40].
The proteomics analysis identified only a limited number of
proteins which were differentially expressed with prenatal iron
restriction. This is partially due to sensitivity and methodology
issues, as the separation of the proteins are limited by the pI range
and size of gel. It may also be due to post translational
modifications allowing a range of spots for a protein, therefore
diluting the potentially significant changes in expression. Despite
these limitations, there was a remarkable similarity between the
microarray and proteomic results in terms of the processes and
pathways affected. These proteins could be broadly categorised by
function, including cytoskeletal remodelling, cell proliferation and
the proteasome complex, which were also identified by the earlier
gatekeeper protein analysis [24]. However, the actual proteins
with significantly differing expression altered between the two
studies. For example, actin-related protein 3 and tubulin a-1 chain
were key gatekeeper proteins associated with cytoskeletal func-
tions, whereas ADP-ribosylation factor-like 3, dihydropyrimidi-
nase-related protein 2 and chaperonin containing TCP1 were
identified in this role with iron deficiency. Only SUG1, a subunit
of the proteasome complex, featured as a significantly affected
protein in both studies. This emphasises the importance of the
complex, which is related to metabolic regulation and cell cycle
progression, in nutritional studies.
A small number of proteins were also significantly differentially
regulated in the same direction at the gene level as shown by the
microarray. Further processes which the proteomics highlighted in
this study were protein folding, unfolding and transport. Failure of
normal folding, accumulation of denatured proteins or failure of
the proteolytic machinery of a cell can lead to a build up of
potentially damaging polypeptides which could cause cellular
dysfunction or trigger apoptosis. The proteasome complex and
molecular chaperones function together as a quality-control
system to selectively eliminate abnormal proteins. A number of
chaperone proteins that were down-regulated following exposure
to a prenatal FeD diet are involved in folding of cytoskeletal
components (chaperonin) and other targets of interest such as p53
(nucleophosmin).
As this study used whole embryos, the gene and protein changes
noted are expressed within a heterogenous cell population.
Therefore a limitation of this study is that it cannot be concluded
that impacted processes are related specifically to development of
any specific organs, systems or tissues. Further work will be needed
to isolate the location of the key genes and proteins affected by
iron deficiency in tissues of interest, such as the kidney. The
dilution effect conferred by using whole embryos may be the
reason for the modest fold-change values found in this study, and
for generalised processes such as cell division being the most highly
impacted by the dietary insult, rather than tissue-specific effects.
As considered in our previous study [24], criteria concerning the
validation of microarray techniques are still being addressed by
investigators in the field [41,42]. However, we are satisfied that
this study was adequately powered and controlled to reveal only
robust results. Importantly these findings corroborate earlier
observations as well as changes in protein expression in the
current study.
Iron deficiency is the greatest micronutrient deficiency among
humans, impacting on pregnant women in both developed and
developing countries. Iron is essential for a variety of metabolic
processes, and in the embryo clearly plays a key role in cellular
proliferation and regulating cell-cycle proteins. This thorough
study has shown that maternal iron deficiency impacts significantly
on genes and proteins which regulate cell proliferation, differen-
tiation and apoptosis in the embryo. These findings may provide
important indicators of the primary mechanisms which link fetal
exposure to maternal undernutrition to the development of
cardiovascular, renal and metabolic disorders later in life.
Supporting Information
Table S1 Summary of genes which changed statistically
significantly in expression in response to the iron
deficient diet.
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